Who we are
As a family-held company, we are cognizant of how work shapes who we are and who we aspire to become.

We want to develop innovative treatments for unmet needs. We are people driven, committed to quality, and innovating for better lives.
We are a global, family-owned company driven by a passion for innovation. Building on our foundational expertise in carbohydrate chemistry and cell cycle biology, we develop innovative treatments for unmet patient needs, with a focus on iron metabolism and blood-related disorders. With 700+ employees across the UK, Ireland, the Nordics, Germany, the USA, and China, we are committed to scientific excellence, patient care, and collaborative partnerships with the medical community. Our core values define who we are. We seek to enhance patient safety and recovery while simplifying treatment management. Our innovative principle is to enable healthcare professionals, patients, and society to achieve more through greater efficiency.
A leader in providing innovative treatments for unmet patient needs, with a focus on iron metabolism and blood related disorders.
Our global presence is strong due to our Denmark-based parent company, Pharmacosmos A/S, as well as our skilled colleagues and partners in all major pharmaceutical markets. Today, Pharmacosmos products are represented in more than 40 countries. This is the key to our accelerated growth and will lay the foundation for future regional and global innovations and partnerships.